News
Filter
-
MRC Technology and AstraZeneca renew collaboration to identify novel targets for discovery research
-
Dementia Consortium wins One Nucleus BioNewsRound Award at ON Helix 2014
-
MRC Technology sells its melanocortin receptors programme to Pfizer Inc
-
MRC Technology and Daiichi Sankyo collaborate to identify novel targets for drug discovery
-
16 applications received for first Dementia Consortium deadline
-
MRC Technology and Chinese Academy of Science extend collaboration to identify new targets for drug discovery
-
UCB and UK’s MRC Technology sign exclusive license agreement for a fibrosis programme
-
£3m Dementia Consortium launched to boost dementia drug discovery
-
MRC Technology to Oversee Parkinson’s UK Intellectual Property
-
MRC Technology and Oxford University Collaborate to Develop Novel Pain Therapeutics for Migraine
-
MRC Technology to join innovation network at Stevenage Bioscience Catalyst
-
MRC Technology and Boston University Collaborate to Develop anti-IL-16 Antibody for Treatment of Inflammatory Conditions
